Antigen presentation to naive CD4 T cells in the lymph node

Nature Immunology

Volumn 4, Issue 8, 2003, Pages 733-739

  Itano, Andrea A ^a   Jenkins, Marc K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; MONOCLONAL ANTIBODY; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BLOOD CELL; CELL MIGRATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; DENDRITIC CELL; IMMUNE RESPONSE; LANGERHANS CELL; LEYDIG CELL; LYMPH NODE; LYMPHOCYTE FUNCTION; LYMPHOID ORGAN; LYMPHOID TISSUE; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPH NODES;

EID: 0042696999     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni957     Document Type: Review

References (88)

1. Banchereau, J. #38; Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
2. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-780 (2001).
3. +T cell tolerance. J. Exp. Med. 196, 1627-1638 (2002).
4. +T-cells from mice transgenic for an αβ T-cell receptor. Cell. Immunol. 166, 62-70 (1995).
5. Cassell, D.J. #38; Schwartz, R.H. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180, 1829-1840 (1994).
6. Jenkins, M.K. et al. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19, 23-45 (2001).
7. von Andrian, U.H. #38; Mackay, C.R. T-cell function and migration. N. Engl. J. Med. 343, 1020-1034 (2000).
8. Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T. #38; Jenkins, M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410, 101-105 (2001).
9. Witmer, M.D. #38; Steinman, R.M. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch. Am. J. Anat. 170, 465-481 (1984).
10. Witmer-Pack, M.D. et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell Sci. 104, 1021-1029 (1993).
11. Chang, M.D., Stanley, E.R., Khalili, H., Chisholm, O. #38; Pollard, J.W. Osteopetrotic (op/op) mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune response. Cell. Immunol. 162, 146-152 (1995).
12. Zhong, G., Sousa, C.R. #38; Germain, R.N. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J. Exp. Med. 186, 673-682 (1997).
13. Lanzavecchia, A. Antigen-specific interaction between T and B cells. Nature 314, 537-539 (1985).
14. Itano, A.A. et al. Distinct dendritic cell populations sequentially present a subcutaneous antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19, 47-57 (2003).
15. Epstein, M.M., Rosa, F.D., Jankovic, D., Sher, A. #38; Matzinger, P. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182, 915-922 (1995).
16. +T cell memory in the absence of B cells and Ig. J. Immunol. 157, 2947-2952 (1996).
17. Townsend, S.E. #38; Goodnow, C.C. Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J. Exp. Med. 187, 1611-1621 (1998).
18. +dendritic cells in vivo. J. Exp. Med. 195, 683-694 (2002).
19. Garside, P. et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281, 96-99 (1998).
20. Fulcher, D.A. et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183, 2313-2328 (1996).
21. Steinman, R.M., Pack, M. #38; Inaba, K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156, 25-37 (1997).
22. MacPherson, G., Kushnir, N. #38; Wykes, M. Dendritic cells, B cells and the regulation of antibody synthesis. Immunol. Rev. 172, 325-334 (1999).
23. Gerosa, F. et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195, 327-333 (2002).
24. +T cells. J. Exp. Med. 185, 2133-2141 (1997).
25. Byersdorfer, C.A. #38; Chaplin, D.D. Visualization of early APC/T cell interactions in the mouse lung following intranasal challenge. J. Immunol. 167, 6756-6764 (2001).
26. Miller, M.J., Wei, S.H., Parker, I. #38; Cahalan, M.D. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296, 1869-1873 (2002).
27. Hommel, M. #38; Kyewski, B. Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes. J. Exp. Med. 197, 269-280 (2003).
28. +T cells in vivo. J. Immunol. 154, 5684-5693 (1995).
29. del Hoyo, G.M. et al. Characterization of a common precursor population for dendritic cells. Nature 415, 1043-1047 (2002).
30. Ruedl, C., Koebel, P., Bachmann, M., Hess, M. #38; Karjalainen, K. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165, 4910-4916 (2000).
31. Anjuere, F. et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 93, 590-598 (1999).
32. Shortman, K. #38; Liu, Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161 (2002).
33. Vremec, D. #38; Shortman, K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159, 565-573 (1997).
34. Traver, D. et al. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 290, 2152-2154 (2000).
35. −dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation. Blood 99, 999-1004 (2002).
36. −dendritic cell subset. Blood 102, 601-604 (2003 ).
37. +cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194, 1171-1178 (2001).
38. +dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J. Immunol. 169, 2247-2252 (2002).
39. Julia, V. et al. A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 16, 271-283 (2002).
40. Yrlid, U. #38; Wick, M.J. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J. Immunol. 169, 108-116 (2002).
41. +dendritic cells. J. Immunol. 166, 5327-5330 (2001).
42. +dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195, 1289-1302 (2002).
43. Manickasingham, S. #38; Reis e Sousa, C. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J. Immunol. 165, 5027-5034 (2000).
44. Henri, S. et al. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167, 741-748 (2001).
45. Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150 (2001).
46. +T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101, 3520-3526 (2003).
47. Dalod, M, et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J. Exp. Med. 197, 885-898 (2003).
48. Krug, A. et al. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J. Exp. Med. 197, 899-906 (2003).
49. Salomon, B., Cohen, J.L., Masurier, C. #38; Klatzmann, D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J. Immunol. 160, 708-717 (1998).
50. Kamath, A.T., Henri, S., Battye, F., Tough, D.F. #38; Shortman, K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100, 1734-1741 (2002).
51. Geissmann, F. et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196, 417-430 (2002).
52. Randolph, G.J., Inaba, K., Robbiani, D.F., Steinman, R.M. #38; Muller, W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11, 753-761 (1999).
53. Lappin, M.B., Kimber, I. #38; Norval, M. The role of dendritic cells in cutaneous immunity. Arch. Dermatol. Res. 288, 109-121 (1996).
54. Macatonia, S.E., Knight, S.C., Edwards, A.J., Griffiths, S. #38; Fryer, P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166, 1654-1667 (1987).
55. Romani, N. et al. Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. Int. Rev. Cytol. 207, 237-270 (2001).
56. Nalefski, E.A. #38; Rao, A. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor. J. Immunol. 150, 3806-3816 (1993).
57. Wang, B., Amerio, P. #38; Sauder, D.N. Role of cytokines in epidermal Langerhans cell migration. J. Leukoc. Biol. 66, 33-39 (1999).
58. Cumberbatch, M. #38; Kimber, I. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 75, 257-263 (1992).
59. Stoitzner, P. et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 120, 266-274 (2003).
60. +Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J. Immunol. 136, 4362-4371 (1986).
61. Kumamoto, T. et al. Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat. Biotechnol. 20, 64-69 (2002).
62. Rudensky, A., Rath, S., Preston-Hurlburt, P., Murphy, D.B. #38; Janeway, C.A., Jr. On the complexity of self. Nature 353, 660-662 (1991).
63. Murphy, D.B. et al. Monoclonal antibody detection of a major self peptide. MHC class II complex. J. Immunol. 148, 3483-3491 (1992).
64. Inaba, K. et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163-2173 (1998).
65. Valladeau, J. et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81 (2000).
66. Vermaelen, K.Y., Carro-Muino, I., Lambrecht, B.N. #38; Pauwels, R.A. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193, 51-60 (2001).
67. Constant, S.L. et al. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110, 1441-1448 (2002).
68. Zhao, X. et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197, 153-162 (2003).
69. Randolph, G.J., Beaulieu, S., Lebecque, S., Steinman, R.M. #38; Muller, W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480-483 (1998).
70. Qu, C., Moran, T.M. #38; Randolph, G.J. Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. J. Immunol. 170, 1010-1018 (2003).
71. Ebnet, K., Kaldjian, E.P., Anderson, A.O. #38; Shaw, S. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 14, 155-177 (1996).
72. Picker, L.J. #38; Siegelman, M.H. in Fundamental Immunology (ed. Paul, W.E.) 145-197 (Raven, New York, 1993).
73. Kaldjian, E.P., Gretz, J.E., Anderson, A.O., Shi, Y. #38; Shaw, S. Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int. Immunol. 13, 1243-1253 (2001).
74. Gretz, J.E., Norbury, C.C., Anderson, A.O., Proudfoot, A.E. #38; Shaw, S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192, 1425-1440 (2000).
75. Okada, S., Albrecht, R.M., Aharinejad, S. #38; Schraufnagel, D.E. Structural aspects of the lymphocyte traffic in rat submandibular lymph node. Microsc. Microanal. 8, 116-133 (2002).
76. Ruedl, C., Koebel, P. #38; Karjalainen, K. In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J. Immunol. 166, 7178-1782 (2001).
77. Turley, S.J. et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288, 522-527 (2000).
78. Finkelman, F.D., Lees, A., Birnbaum, R., Gause, W.C. #38; Morris, S.C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157, 1406-1414 (1996).
79. Lu, Q. #38; Lemke, G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293, 306-311 (2001).
80. Scott, R.S. et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207-211 (2001).
81. Savill, J. #38; Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784-788 (2000).
82. Fadok, V.A. et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85-90 (2000).
83. Fadok, V.A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF J. Clin. Invest. 101, 890-898 (1998).
84. Ding, L., Linsley, P.S., Huang, L.Y., Germain, R.N. #38; Shevach, E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151, 1224-1234 (1993).
85. Inaba, K. et al. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186, 665-672 (1997).
86. Zhong, G., Reis e Sousa, C. #38; Germain, R.N. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94, 13856-13861 (1997).
87. Dadaglio, G., Nelson, C.A., Deck, M.B., Petzold, S.J. #38; Unanue, E.R. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6, 727-738 (1997).
88. Porgador, A., Yewdell, J.W., Deng, Y., Bennink, J.R. #38; Germain, R.N. Localization, quantitation, and in situ detection of specific peptide- MHC class I complexes using a monoclonal antibody. Immunity 6, 715-726 (1997).